OtherINTERVENTIONAL
Neurobehavioral Differences in Superselective Wada Testing with Amobarbital versus Lidocaine
Brian-Fred M. Fitzsimmons, Randolph S. Marshall, John Pile-Spellman and Ronald M. Lazar
American Journal of Neuroradiology August 2003, 24 (7) 1456-1460;
Brian-Fred M. Fitzsimmons
aCerebrovascular Center of the Neurological Institute, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY
cCerebrovascular Center of the Neurological Institute, Department of Neurosurgery, Columbia University College of Physicians and Surgeons, New York, NY
Randolph S. Marshall
aCerebrovascular Center of the Neurological Institute, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY
John Pile-Spellman
bCerebrovascular Center of the Neurological Institute, Department of Radiology, Columbia University College of Physicians and Surgeons, New York, NY
cCerebrovascular Center of the Neurological Institute, Department of Neurosurgery, Columbia University College of Physicians and Surgeons, New York, NY
Ronald M. Lazar
aCerebrovascular Center of the Neurological Institute, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY
cCerebrovascular Center of the Neurological Institute, Department of Neurosurgery, Columbia University College of Physicians and Surgeons, New York, NY
In this issue
American Journal of Neuroradiology
Vol. 45, Issue 4
1 Apr 2024
Neurobehavioral Differences in Superselective Wada Testing with Amobarbital versus Lidocaine
Brian-Fred M. Fitzsimmons, Randolph S. Marshall, John Pile-Spellman, Ronald M. Lazar
American Journal of Neuroradiology Aug 2003, 24 (7) 1456-1460;
Related Articles
- No related articles found.
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement